P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension

Sandborn William; Feagan Brian; Hanauer Stephen; Vermeire Séverine; Ghosh Subrata; Liu Wenzhong; Petersen AnnKatrin; Charles Lorna; Huang Vivian; Usiskin Keith; Wolf Doug; D'Haens Geert

doi:10.14309/01.ajg.0000722920.48091.e7

P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension

Sandborn William, Feagan Brian, Hanauer Stephen, Vermeire Séverine, Ghosh Subrata, Liu Wenzhong, Petersen AnnKatrin, Charles Lorna, Huang Vivian, Usiskin Keith, Wolf Doug, D'Haens Geert

Medicine, Gastroenterology Division

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S8
Journal	The American journal of gastroenterology
Volume	115
DOIs	https://doi.org/10.14309/01.ajg.0000722920.48091.e7
State	Published - Dec 1 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.14309/01.ajg.0000722920.48091.e7

Cite this

William, S., Brian, F., Stephen, H., Séverine, V., Subrata, G., Wenzhong, L., AnnKatrin, P., Lorna, C., Vivian, H., Keith, U., Doug, W., & Geert, DH. (2020). P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension. The American journal of gastroenterology, 115, S8. https://doi.org/10.14309/01.ajg.0000722920.48091.e7

@article{c1466a4a587a4e1bb73334bb4b363218,

title = "P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension",

author = "Sandborn William and Feagan Brian and Hanauer Stephen and Vermeire S{\'e}verine and Ghosh Subrata and Liu Wenzhong and Petersen AnnKatrin and Charles Lorna and Huang Vivian and Usiskin Keith and Wolf Doug and D'Haens Geert",

year = "2020",

month = dec,

day = "1",

doi = "10.14309/01.ajg.0000722920.48091.e7",

language = "English (US)",

volume = "115",

pages = "S8",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

}

William, S, Brian, F, Stephen, H, Séverine, V, Subrata, G, Wenzhong, L, AnnKatrin, P, Lorna, C, Vivian, H, Keith, U, Doug, W & Geert, DH 2020, 'P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension', The American journal of gastroenterology, vol. 115, pp. S8. https://doi.org/10.14309/01.ajg.0000722920.48091.e7

TY - JOUR

T1 - P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis

T2 - Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension

AU - William, Sandborn

AU - Brian, Feagan

AU - Stephen, Hanauer

AU - Séverine, Vermeire

AU - Subrata, Ghosh

AU - Wenzhong, Liu

AU - AnnKatrin, Petersen

AU - Lorna, Charles

AU - Vivian, Huang

AU - Keith, Usiskin

AU - Doug, Wolf

AU - Geert, D'Haens

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85101472730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101472730&partnerID=8YFLogxK

U2 - 10.14309/01.ajg.0000722920.48091.e7

DO - 10.14309/01.ajg.0000722920.48091.e7

M3 - Article

C2 - 33566505

AN - SCOPUS:85101472730

VL - 115

SP - S8

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

ER -

P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this